* Number of participants in the vaccine group: 21,720
* Number of participants in the placebo group: 21,728
* Number of COVID-19 cases in the vaccine group: 9
* Number of COVID-19 cases in the placebo group: 169

Reported effectiveness and CI: 94.6 % effectiveness (95% CI [89.9, 97.3])

# References: 

* [Press release 10th December 2020](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-publication-results-landmark)
* [Press release 18th November 2020](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine)
